Alabama is set to receive nearly a quarter of a billion dollars from a $17.3 billion multi-state opioid settlement with pharmacies CVS and Walgreens and drug manufacturers Teva Pharmaceuticals and Allergan, state Attorney General Steve Marshall announced Friday.

The defendants have agreed to release funds to a national administrator later in the summer, and Alabama is expected to start receiving the money by the end of the year, Marshall said.

“The opioid crisis is a blight on our society and has had costly effects on our communities,” the attorney general said in a statement. “My office will never stop holding those responsible companies accountable for the irreparable harm to our state.”

Under the settlement terms, Teva’s opioid business cannot market the highly addictive drugs and will have to “ensure systems are in place to prevent drug misuse,” the attorney general’s office said.

Allergan is also banned from selling opioids for 10 years, while CVS and Walgreens are required to monitor, report and share data about suspicious activity related to opioid prescriptions.

Alabama is receiving $249 million as part of the settlement.

Teva and Allergan negotiations were led by attorneys general from North Carolina, Iowa, California, Illinois, Maryland, Massachusetts, New York, Pennsylvania, Tennessee, Texas, Vermont, Virginia, and Wisconsin. CVS and Walgreens negotiations were led by attorneys general from North Carolina, California, Colorado, Connecticut, Delaware, Illinois, Indiana, Iowa, Kentucky, Louisiana, Massachusetts, Nebraska, New York, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas.